# NAD+ and inflammation

2 papers in the library, strongest Moderate.

**Graded Moderate**: Narrative review pulling together mechanistic and largely preclinical work on mitochondrial aging, with the proposed rejuvenation strategies not yet tested in people.

## Papers (2)

- [Why Your Mitochondria May Be Driving Aging and Chronic Inflammation](https://usa-longevity.com/en/research/why-your-mitochondria-may-be-driving-aging-and-chronic-inflammation) · Moderate · 2026 · npj aging
- [NMN Calmed Eye Inflammation and Slowed Blood Vessel Damage in Mice](https://usa-longevity.com/en/research/nmn-calmed-eye-inflammation-and-slowed-blood-vessel-damage-in-mice) · Preliminary · n = 57 · 2026 · Investigative ophthalmology & visual science

## How this map is computed

A mark's size is the number of papers we hold on that pairing. It is a count, not a weighting by study design or sample size.

The fill shows the strongest grade in the cell. One Strong paper among four Preliminary ones still fills it dark, so open the cell to see the rest.

Grades and verdicts are assigned by a named person, never by counting.

An empty cell is a finding: nobody in our library has run that trial yet.

---

_Canonical: https://usa-longevity.com/en/evidence/nad-precursors/inflammation · Part of Longevity Cities_